Investigational new drug enabling angiotensin oral-delivery studies to attenuate pulmonary hypertension-Reference-Cited by-同舟云学术

Investigational new drug enabling angiotensin oral-delivery studies to attenuate pulmonary hypertension

Published:2020-03 Issue: Volume:233 Page:119750
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Daniell Henry,Mangu Venkata,Yakubov Bakhtiyor,Park Jiyoung,Habibi Peyman,Shi Yao,Gonnella Patricia A.,Fisher Amanda,Cook Todd,Zeng Lily,Kawut Steven M.,Lahm Tim

Funder

NIH

NHLBI

National Heart Lung and Blood Institute

National Institutes of Health

Department of Health and Human Services

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference66 articles.

1. Vaccination via chloroplast genetics: affordable protein drugs for the prevention and treatment of inherited or infectious human diseases;Daniell;Annu. Rev. Genet.,2016

2. Plant cell-made protein antigens for induction of oral tolerance;Daniell;Biotechnol. Adv.,2019

3. Oral delivery of protein drugs bioencapsulated in plant cells;Kwon;Mol. Ther.,2016

4. Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide;Boyhan;Plant Biotechnol. J,2011

5. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells;Kwon;Plant Biotechnol. J,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cells to improve transport of nanomedicines;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies;International Journal of Molecular Sciences;2023-12-13

3. Russia's attacks on civilians strengthen Ukrainian resistance;PNAS Nexus;2023-12-01

4. A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery;PNAS Nexus;2023-11-28

5. Delivery of biologics: Topical administration;Biomaterials;2023-11